Montelukast Prescribing at DR SPENCER & PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,578
Total Quantity
44.5K
NHS Cost
£2.2K
vs National Avg
+130.5%
DR SPENCER & PARTNERS prescribed 1,578 items of Montelukast over the last 12 months at a cost of £2,226 to the NHS. This is 130.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
153
Jul 2026
131
Jul 2026
144
Jul 2026
135
Jul 2026
132
Jul 2026
134
Jul 2026
118
Jul 2026
134
Jul 2026
144
Jul 2026
116
Jul 2026
120
Jul 2026
117
Prescribing Details
| Total Items | 1,578 |
|---|---|
| Total Quantity | 44,471 |
| Total NHS Cost | £2,226 |
| Presentations | 4 different forms |
| vs National Average | +130.5% |
Montelukast Prescribing Comparison
| This practice | 1,578 items |
|---|---|
| National average per practice | 685 items |
| Difference | +130.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.